# F.D.A. Rejects Closely Watched Lung Cancer Drug From China

> HelixNews · Web page: https://helixnews.one/story/5707653 · All pages for agents: https://helixnews.one/llms.txt

2 outlets covering · First listed: New York Times, Nov 15, 2026, 2:33 PM · Read it: <https://www.nytimes.com/2026/11/15/business/fda-lung-cancer-drug-china.html>

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

## Who's covering it

In the order they published:

- Nov 15, 2026, 11:07 AM: [FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector](<https://www.ft.com/content/390948a3-429c-410a-b5fe-54cc5a380b99?syn-25a6b1a6=1>) — Financial Times (Newspaper, United Kingdom, rated Center)
  Summit’s Ivonescimab was seen as a test case for whether the country’s medicine could pass scrutiny in the US
- Nov 15, 2026, 2:33 PM: [F.D.A. Rejects Closely Watched Lung Cancer Drug From China](<https://www.nytimes.com/2026/11/15/business/fda-lung-cancer-drug-china.html>) — New York Times (Newspaper, United States, rated Lean left)
  The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.